-
The NIH has halted the estrogen-alone wing of the Womens Health Initiative a year before its scheduled end.
-
-
The field of hyperbaric medicine is an evolving specialty, and the scope and practice is fluid with new research. This article will give an explanation into the various approved indications, the basic science rationale, and the pathophysiolgy of why hyperbaric medicine works.
-
Sulfonamide Antibiotics and Sulfonamide Nonantibiotics; Autoantibodies
Before Onset of SLE; Prevention of VTE with Ximelagatran; Combined
Levothyroxine Plus Liothyronine Compared to Levothyroxine Alone in
Primary Hypothyroidism; Specific Site Involvement in Fixed Drug
Eruption; Anticoagulation Therapy for Stroke Prevention in Patients
with Atrial Fibrillation
-
Many therapeutic options now are available to prevent and treat osteoporosis, and consist of non-drug and drug or hormonal therapy. In just one decade, osteoporosis has been transformed from a disorder considered to be an inevitable and irreversible consequence of aging to a disorder in which there now is true therapeutic optimism. This article discusses the definition, epidemiology, and different causes of osteoporosis. Diagnostic studies, including bone densitometry, are reviewed as well as the various therapies.
-
A once-a-day dose of a valacyclovir reduces the rate of transmission of genital herpes (HSV-2) from an infected partner to an uninfected susceptible partner, according to a new study.
-
The first head-to-head comparison study of an ACE inhibitor and an angiotensin receptor blocker, to assess renoprotective effects in type 2 diabetes, has shown that the drugs are comparable in their benefit.
-
-
Clinicians should become confident in management of constipation for numerous reasons, not the least of which is the sheer magnitude of its prevalence in the ambulatory setting.
-
The British government will soon allow over-the-counter (OTC) sales of Mercks simvastatin (Zocor), marking the first time any country has allowed the OTC sale of a statin.